CRISPR targeting of SNPs associated with age-related macular degeneration in ARPE-19 cells: a potential model for manipulating the complement system
Salman A. et al, (2025), Gene Therapy, 32, 132 - 141
Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degeneration
Yusuf IH. et al, (2024), Molecular Therapy, 32, 1445 - 1460
CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues
Salman A. et al, (2024), International Journal of Molecular Sciences, 25, 1697 - 1697
Developmental Expression of the Cell Cycle Regulator p16INK4a in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes?
Martinez-Fernandez de la Camara C. et al, (2023), Journal of Histochemistry & Cytochemistry, 71, 301 - 320
CRISPR approach for allele-specific targeting of SNPs associated with Age-related Macular Degeneration in ARPE19 cells
Salman A. et al, (2023), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 64
Testing cone targeting with AAV5 and the GRK1 promoter in mice for future CRISPR-based applications
Rhodes E. et al, (2023), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 64
Minicircle Delivery to the Neural Retina as a Gene Therapy Approach
Staurenghi F. et al, (2022), International Journal of Molecular Sciences, 23, 11673 - 11673
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations
Salman A. et al, (2022), Pharmaceutics, 14, 1842 - 1842
A novel mouse model of Usher Syndrome Type II designed for testing of base editing therapeutics
Major L. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63
Allele-specific targeting of AMD-related SNPs in ARPE19 cells using a CRISPR Cas9 dual plasmid targeting approach
Rhodes E. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63
CRISPR approach for allele-specific targeting of SNPs associated with Age-related Macular Degeneration in ARPE19 cells
Salman A. et al, (2022), HUMAN GENE THERAPY, 33, A155 - A155
Development of a minicircle gene therapy system for expanding treatment options of inherited retinal disease
Staurenghi F. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63
Development of CRISPR-Cas9 repressors for targeted epigenome editing
Kantor A. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63
In vitro characterisation of spontaneously immortalised Non-Human Primate Muller glia cell lines as a potential source for cell replacement therapies for retinal degenerative eye disease
Salman A. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63
The role of immune checkpoint ligands in retinal immune homeostasis and inflammation
Quinn J. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63
Validation of a rod photoreceptor-specific promoter for CRISPR gene therapy
McClements ME. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63
Insights on the Regeneration Potential of Müller Glia in the Mammalian Retina
Salman A. et al, (2021), Cells, 10, 1957 - 1957
CRISPR genome engineering for retinal diseases
Kantor A. et al, (2021), Progress in Molecular Biology and Translational Science
Characterization of the Frmd7 Knock-Out Mice Generated by the EUCOMM/COMP Repository as a Model for Idiopathic Infantile Nystagmus (IIN)
Salman A. et al, (2020), Genes, 11, 1157 - 1157